Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

UK will label drugs with their cost to the state

The UK health minister has announced plans to label all British prescription medicines with their cost to the taxpayer.

Canadian manufacturer hit with warning letter over cross-contamination issues

Toronto-based Attix Pharmaceuticals has received a US FDA warning letter after an inspection from November and a lack of corrective actions in the company’s response to the FDA.

Staff cuts and accelerated access: MHRA’s plan for 2016

MHRA, the UK pharma regulator, says its staff cuts over the next three years will not impact its work with pharma.

Allergan targets Actavis legacy plant in Iceland in cost-cutting move

Manufacturing operations at an Actavis legacy site in Iceland will cease and products will be transferred out the country from 2016, Allergan has announced.

Capsugel completes $25m SDD expansion at Bend site

Capsugel has pledged to continue investing internally in drug delivery R&D after completing construction of a spray-dried dispersion (SDD) commercial manufacturing site in Oregon.

Hospira's Vizag plant begins sterile production following US FDA approval

Hospira has begun commercial production at a sterile injectable plant in India hit with several 483 forms after the US FDA deemed the site ‘acceptable.’

Key Industry Events


Access all events listing

Our events, Shows & Conferences...